Identification of CDC5L as bridge gene between chronic obstructive pulmonary disease and lung adenocarcinoma

Epigenomics. 2020 Sep;12(17):1515-1529. doi: 10.2217/epi-2020-0112. Epub 2020 Jun 16.

Abstract

Aim: This study aimed to explore the genetic and epigenetic similarities between chronic obstructive pulmonary disease (COPD) and lung adenocarcinoma (LUAD). Materials & methods: We mainly used Weighted correlation network analysis, protein-protein interaction network and pivot analysis to identify hub modules, bridge regulators, bridge genes and hub-driving genes in both diseases and carried out verifying using external datasets. Results: We identified eight bridge regulators, 19 key molecules in the COPD model and ten key molecules in the LUAD model. Moreover, we validated that CDC5L could be a reliable biomarker in COPD and may regulate cell proliferation and metastasis in LUAD via promoter methylation. Conclusion: Our results might form a theoretical foundation for future study at an epigenetic level.

Keywords: CDC5L; biomarker; cancer metastasis; cancer proliferation; chronic obstructive pulmonary disease; epigenetics; lung adenocarcinoma; methylation; the Cancer Genome Atlas; transcription factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung / genetics*
  • Biomarkers*
  • Biomarkers, Tumor
  • Cell Cycle Proteins / genetics*
  • Cell Proliferation
  • DNA Methylation
  • Epigenesis, Genetic
  • Gene Expression Profiling
  • Gene Expression Regulation*
  • Gene Expression Regulation, Neoplastic
  • Gene Regulatory Networks*
  • Humans
  • Pulmonary Disease, Chronic Obstructive / genetics*
  • RNA-Binding Proteins / genetics*

Substances

  • Biomarkers
  • Biomarkers, Tumor
  • CDC5L protein, human
  • Cell Cycle Proteins
  • RNA-Binding Proteins